IGF1 and major depressive disorder: No significant confounding factors were found to explain the high level of heterogeneity using β and subgroup analyses; however, subgroup analyses detected significant differences in IGF-1 levels between MDD patients and healthy controls only in serum samples, and studies measuring serum samples had lower heterogeneity than studies measuring plasma.